Cytrx Corp. (CYTR) Stock Price & Overview

NASDAQ:CYTR

Current stock price

0.31
-0.07 (-18.38%)
At close:
0.31
0 (0%)
After Hours:

The current stock price of CYTR is 0.31 null. Today CYTR is down by -18.38%. In the past month the price decreased by -39.29%. In the past year, price decreased by -76.87%.

CYTR Key Statistics

52-Week Range0.3 - 1.36
Current CYTR stock price positioned within its 52-week range.
1-Month Range0.3 - 0.62
Current CYTR stock price positioned within its 1-month range.
Market Cap
10.428M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.29
Dividend Yield
N/A

CYTR Stock Performance

Today
-18.38%
1 Week
-44.63%
1 Month
-39.29%
3 Months
-54.68%
Longer-term
6 Months -43.64%
1 Year -76.87%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

CYTR Stock Chart

Cytrx Corp. / CYTR Daily stock chart

CYTR Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to CYTR. When comparing the yearly performance of all stocks, CYTR is a bad performer in the overall market: 98.2% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
CYTR Full Technical Analysis Report

CYTR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CYTR. CYTR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CYTR Full Fundamental Analysis Report

CYTR Earnings

Next Earnings DateMay 11, 2022
Last Earnings DateMar 23, 2022
CYTR Earnings History

CYTR Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next Y17.24%
Revenue Next YearN/A
CYTR Forecast & Estimates

CYTR Financial Highlights

Over the last trailing twelve months CYTR reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 80.92% compared to the year before.


Income Statements
Revenue(TTM)250.00K
Net Income(TTM)-10.06M
Industry RankSector Rank
PM (TTM) -4025.6%
ROA -46.79%
ROE -52.56%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%69.7%
Sales Q2Q%N/A
EPS 1Y (TTM)80.92%
Revenue 1Y (TTM)150%
CYTR financials

CYTR Ownership

Ownership
Inst Owners0%
Shares33.64M
Float31.62M
Ins Owners29.85%
Short Float %N/A
Short RatioN/A
CYTR Ownership

About CYTR

Company Profile

CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.

Company Info

Cytrx Corp.

11726 SAN VICENTE BOULEVARD SUITE 650

LOS ANGELES CA 90049

CEO: Steven A. Kriegsman

Phone: 310-826-5648

Cytrx Corp. / CYTR FAQ

Can you describe the business of Cytrx Corp.?

CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.


Can you provide the latest stock price for Cytrx Corp.?

The current stock price of CYTR is 0.31 null. The price decreased by -18.38% in the last trading session.


What is the dividend status of Cytrx Corp.?

CYTR does not pay a dividend.


What is the ChartMill rating of Cytrx Corp. stock?

CYTR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the market cap for Cytrx Corp.?

Cytrx Corp. (CYTR) has a market capitalization of 10.43M null. This makes CYTR a Nano Cap stock.